You are here

Bumper haul of expensive new drugs heads to US, Europe

The high prices charged for modern drugs is generating push-back from healthcare providers, patients and some doctors.


DRUG companies have brought a host of expensive new medicines to market in the United States and Europe this year, figures show, another bumper haul for an industry often accused of over-charging.

Drug prices are set to be a major issue in the run-up to the US presidential...